Register to attend a free NIH webinar. Attendees will learn about a new method for treating glaucoma using exosomes derived from bone marrow-derived mesenchymal stem cells (BMSC). The webinar will be presented by Dr. Stanislav Tomarev (Senior Investigator, Retinal Ganglion Cell Biology, NIH National Eye Institute) and Dr. Ben Mead (Neuroscientist, Cardiff University Exosome and Retinal Research Group).

Webinar overview:

The inventors will discuss their discovery that BMSC‐derived exosome administration for glaucoma may confer a significant neuroprotective effect for retinal ganglion cells (RGCs) and prevent vision loss, and how their isolated BMSC-derived exosomes have several immediate advantages for clinical translation compared to potential whole-cell (stem cell) therapies currently being used to treat glaucoma.